The emergence of the coronavirus disease 2019 (COVID-19) as a pandemic in the first half of 2020 had a direct and major impact on the treatment of cancer. The COVID-19 pandemic has had a negative impact on cancer care in a variety of ways, with varying degrees of severity around the world. Being a vulnerable group, people with cancer are subject to a number of issues during pandemics, including as increased susceptibility to infection and disruptions in their normal or cancer treatment. One of the most significant concerns for clinicians is the possibility of cardiovascular problems in cancer patients who have also been infected with SARS-CoV-2. Another issue with COVID-19 positive cancer patients is the renin-angiotensin-aldosterone system (RAAS).
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
